Lawyers for the Lifecycle of Food, Dietary Supplement & Cosmetic Products; Brand to Generic Drug Leaders

Amin Talati Continues Its Expansion In Washington DC With Addition Of Dietary Supplement Industry Leader

We are delighted to announce that Rend Al-Mondhiry has joined the firm from the Council for Responsible Nutrition (CRN). She will be Senior Counsel, resident in the Washington, D.C. Office. “The depth and breadth of MORE >

see all news >

Food & Beverage

We support clients throughout the entire lifecycle of products aimed at improving the population's health and wellness: food and beverages, nutritional supplements, cosmetics, medical devices and pharmaceuticals.


Intellectual Property

Drawing heavily on our IP, patent and trademark expertise, we provide our clients with business advice and strategies that enhance product value and head off future litigation.



We are deeply experienced in FDA and FTC disputes, patent and trademark infringement cases, class actions, breach of contract and unfair competition claims. We are renowned in the area of Paragraph IV litigation, where companies challenge brand name patents so that medications can be marketed in generic forms.


Brand to Generic Drug

We provide counseling both to generic companies seeking to challenge patents and bring drugs to market, and to brand name pharmaceutical companies seeking to strategically patent and protect their brand name products in the long term.

What's New
  • news

    Shashank Upadhye will be Speaking at ACI’s 12th Annual Paragraph IV Disputes Conference

    Shashank Upadhye will be speaking at ACI’s 12th Annual Paragraph IV Disputes conference in New York on April 23, 2018. The Paragraph IV conference is one of the biggest and most important conferences in the brand-generic drug industry. Learn more and attend the conference HERE.

  • news

    Upadhye to Be Featured Speaker at CPHI North America in April

    Shashank Upadhye will be giving an Insight Briefing at the CPHI North America conference in Philadelphia on Tuesday, April 24, 2018. He will speak about IP/patent issues facing API and FDF companies, how to create defensible legal strategies, reduce costs, and improve licensing abilities. Learn more about the CPHI event HERE.

  • news

    Shashank Upadhye was a Featured Speaker at the 7th Pharma IP Summit in Mumbai this March

    Shashank Upadhye spoke at the 7th pharma IP summit in Mumbai in March 2018. He gave two different talks. The first was about how to manage legal/litigation costs by speaking about best practices that both law firms and clients can implement to reduce costs. Because of his long in-house experience, he spoke about cost controls […]